CTSH
56
2
NOC
43
11
ROP
62
3
KMI
67
-2
AAP
24
6
BSX
67
-3
GPC
40
3
APD
59
2
PGR
65
2
MET
72
5
HCP
66
8
FITB
63
3
YUM
47
3
DTE
56
2
ES
34
3
HOG
35
2
SO
53
-4
PNC
64
4
RIG
60
2
HAS
33
3
CTSH
56
2
NOC
43
11
ROP
62
3
KMI
67
-2
AAP
24
6
BSX
67
-3
GPC
40
3
APD
59
2
PGR
65
2
MET
72
5
HCP
66
8
FITB
63
3
YUM
47
3
DTE
56
2
ES
34
3
HOG
35
2
SO
53
-4
PNC
64
4
RIG
60
2
HAS
33
3
Financhill
Back

Cingulate Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
29

CING
Cingulate

Last Price:
4.75
Seasonality Move:
-27.84%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
1.46%
Sell
29
Cingulate (CING) is a Sell

Is Cingulate a Buy, Sell or Hold?

  • The current Cingulate [CING] share price is $4.72. The Score for CING is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • CING is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CING Stock Price Chart

What is Cingulate's stock price today?

  • The Cingulate share price today is $4.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CING is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

CING Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 56.7 Buy
Chaikin Money Flow: 40665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.78 - 4.68) Buy
Bollinger Bands (100): (2.86 - 7.56) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

CING Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.34 Buy
20-day SMA: 4.1 Buy
50-day SMA: 4.55 Buy
200-day SMA: 8.13 Sell
8-day EMA: 4.38 Buy
20-day EMA: 4.29 Buy
50-day EMA: 4.72 Buy
200-day EMA: 23.43 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Cingulate Earnings Growth & CING Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.68 per share, a decrease next quarter of $0.00 per share, an increase this year of $315.94 per share, and an increase next year of $5.20 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Cingulate Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):